WSO - April 2024 - 402

402
International Journal of Stroke 19(4)
Table 2. Critical appraisal summary of the included reviews.
Study
Bagheri et al.11
Huang et al.6
Oesch et al.2
Torres-Aguila et al.12
MacDonald et al.3
Zhang et al.4
Mehta et al.5
C1
N
U
U
U
Y
U
Y
C2
Y
Y
Y
U
Y
Y
Y
C3
Y
Y
U
N
Y
Y
U
C4
Y
U
N
N
Y
U
Y
C5
Y
Y
N
N
Y
Y
Y
C6
U
Y
N
N
Y
Y
Y
C7
Y
Y
U
N
Y
Y
Y
C8
U
Y
U
U
Y
Y
Y
C9
Y
Y
U
N
N
Y
Y
C10
U
U
U
U
U
U
U
C11
Y
Y
Y
U
Y
Y
Y
N = no; Y = yes; U = unclear; C1. Is the review question explicitly stated? C2. Were the inclusion criteria appropriate for the review question? C3.
Was the search strategy appropriate? C4. Were the sources and resources used to search for studies adequate? C5. Were the criteria for appraising
studies appropriate? C6. Was critical appraisal conducted by two or more reviewers independently? C7. Were there methods to minimize errors
in data extraction? C8. Were the methods used to combine studies appropriate? C9. Was the likelihood of publication bias assessed? C10. Were
recommendations for policy and/or practice supported by the reported data? C11. Were the specific directives for new research appropriate?
Table 3. Summary of main results (for each outcome measure categorized by body weight).
Systematic review
All-cause mortality
Bagheri et al.11
Huang et al.6
Oesch et al.2
Number of relevant
studies (number of
participants)
8 (95,651)
14 (102,226)
10 (162,921)
Torres-Aguila et al.12 2 (1961)
Zhang et al.4
Mehta et al.5
2 (NR)
Underweight 5 (1948)
Overweight 6 (42,814)
Obese 6 (6052)
Functional recovery
Oesch et al.2
9 (92,718)
Torres-Aguila et al.12 2 (1961)
MacDonald et al.3
Underweight 4 (1987);
Overweight N/A;
Obese 7 (3070)
Zhang et al.4
Underweight 4 (NR);
overweight 6 (NR);
obese 6 (NR)
Mehta et al.5
Overweight 2 (795)
Obese 2 (627)
Heterogeneity
High
High
NR
NR
Low
High
High
Low
NR
NR
NR
Low
Moderate
Underweight
(BMI < 18.5 kg/m2)
HR < 1.0
RR = 1.54
No HR reported
(increased mortality)
No HR reported
(no association)
uHR = 2.24
aHR = 1.65
Overweight
(BMI = 25-29.9 kg/m2) Obese (BMI > 30 kg/m2)
HR > 1.0
RR = 0.83
No HR reported
(decreased mortality)
No HR reported
(no association)
uHR = 0.83
aHR = 0.80
HR > 1.0
RR = 0.83
No HR reported
(decreased mortality)
No HR reported
(no association)
uHR = 0.83
aHR = 0.80
No OR reported
(decreased functional
recovery)
No OR reported
(no association)
No OR reported
(decreased functional
recovery)
uOR = 1.63
aOR = 2.21
No OR reported
(increased functional
recovery)
No OR reported
(no association)
No OR reported
(inconclusive findings)
uOR = 0.94
MD = 0.50
No significant
association
No OR reported
(increased functional
recovery)
No OR reported
(no association)
No OR reported
(inconclusive findings)
uOR = 0.93
MD = 2.26
No significant association
BMI: body mass index; HR: hazard ratio; RR: relative risk; NR: not reported; uHR: unadjusted hazard ratio; aHR: adjusted hazard ratio; OR: odds
ratio; N/A: not applicable; uOR: unadjusted odds ratio; aOR: adjusted odds ratio; MD: mean difference.
International Journal of Stroke, 19(4)

WSO - April 2024

Table of Contents for the Digital Edition of WSO - April 2024

Content
WSO - April 2024 - Cover1
WSO - April 2024 - Cover2
WSO - April 2024 - 373
WSO - April 2024 - Content
WSO - April 2024 - 375
WSO - April 2024 - 376
WSO - April 2024 - 377
WSO - April 2024 - 378
WSO - April 2024 - 379
WSO - April 2024 - 380
WSO - April 2024 - 381
WSO - April 2024 - 382
WSO - April 2024 - 383
WSO - April 2024 - 384
WSO - April 2024 - 385
WSO - April 2024 - 386
WSO - April 2024 - 387
WSO - April 2024 - 388
WSO - April 2024 - 389
WSO - April 2024 - 390
WSO - April 2024 - 391
WSO - April 2024 - 392
WSO - April 2024 - 393
WSO - April 2024 - 394
WSO - April 2024 - 395
WSO - April 2024 - 396
WSO - April 2024 - 397
WSO - April 2024 - 398
WSO - April 2024 - 399
WSO - April 2024 - 400
WSO - April 2024 - 401
WSO - April 2024 - 402
WSO - April 2024 - 403
WSO - April 2024 - 404
WSO - April 2024 - 405
WSO - April 2024 - 406
WSO - April 2024 - 407
WSO - April 2024 - 408
WSO - April 2024 - 409
WSO - April 2024 - 410
WSO - April 2024 - 411
WSO - April 2024 - 412
WSO - April 2024 - 413
WSO - April 2024 - 414
WSO - April 2024 - 415
WSO - April 2024 - 416
WSO - April 2024 - 417
WSO - April 2024 - 418
WSO - April 2024 - 419
WSO - April 2024 - 420
WSO - April 2024 - 421
WSO - April 2024 - 422
WSO - April 2024 - 423
WSO - April 2024 - 424
WSO - April 2024 - 425
WSO - April 2024 - 426
WSO - April 2024 - 427
WSO - April 2024 - 428
WSO - April 2024 - 429
WSO - April 2024 - 430
WSO - April 2024 - 431
WSO - April 2024 - 432
WSO - April 2024 - 433
WSO - April 2024 - 434
WSO - April 2024 - 435
WSO - April 2024 - 436
WSO - April 2024 - 437
WSO - April 2024 - 438
WSO - April 2024 - 439
WSO - April 2024 - 440
WSO - April 2024 - 441
WSO - April 2024 - 442
WSO - April 2024 - 443
WSO - April 2024 - 444
WSO - April 2024 - 445
WSO - April 2024 - 446
WSO - April 2024 - 447
WSO - April 2024 - 448
WSO - April 2024 - 449
WSO - April 2024 - 450
WSO - April 2024 - 451
WSO - April 2024 - 452
WSO - April 2024 - 453
WSO - April 2024 - 454
WSO - April 2024 - 455
WSO - April 2024 - 456
WSO - April 2024 - 457
WSO - April 2024 - 458
WSO - April 2024 - 459
WSO - April 2024 - 460
WSO - April 2024 - 461
WSO - April 2024 - 462
WSO - April 2024 - 463
WSO - April 2024 - 464
WSO - April 2024 - 465
WSO - April 2024 - 466
WSO - April 2024 - 467
WSO - April 2024 - 468
WSO - April 2024 - 469
WSO - April 2024 - 470
WSO - April 2024 - 471
WSO - April 2024 - 472
WSO - April 2024 - 473
WSO - April 2024 - 474
WSO - April 2024 - 475
WSO - April 2024 - 476
WSO - April 2024 - 477
WSO - April 2024 - 478
WSO - April 2024 - Cover3
WSO - April 2024 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com